GHOSH ANIRVAN (Chief Executive Officer) sold 38.7% of their position (96.80K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $99.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2025ACC: 0000950170-25-050397
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-96.80K
Net shares
Net seller
$99.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
96.80K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−96.80K
Price / share
$1.03
Trade value
$99.70K
% of position
38.7%
4/2/2025
250.25K→153.45K
Total
Net shares
−96.80K
Net value
-$99.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 4/2/2025 | S · Sale | −96.80K | $1.03 | $99.70K | 38.7% | 250.25K | 153.45K |
| Total | −96.80K | -$99.70K | ||||||
Derivative Transactions0
No derivative transactions reported